AAUM (Average Assets Under Management) of ₹18.92 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 75.8% | 76.1% | ▲ +0.4% |
| Healthcare Services | 23.7% | 23.3% | ▼ -0.5% |
| Healthcare Equipment & Supplies | 0.5% | 0.5% | ● 0.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 76.1% | 77.1% | ▲ +1.0% |
| Healthcare Services | 23.3% | 22.5% | ▼ -0.8% |
| Healthcare Equipment & Supplies | 0.5% | 0.5% | ● 0.0% |
Comparing Jul 2026 → Aug 2026
| # | Stock | Sector | Jul 2026 | Aug 2026 | Change |
|---|---|---|---|---|---|
| 1 | Divi's Laboratories Limited ₹1.52 Cr |
Pharmaceuticals & Biotechnology | 6.38% | 7.22% | +0.84% |
| 2 | Shilpa Medicare Ltd ₹14.36 L |
Pharmaceuticals & Biotechnology | 0.45% | 0.68% | +0.23% |
| 3 | Glenmark Pharmaceuticals Limited ₹48.00 L |
Pharmaceuticals & Biotechnology | 2.08% | 2.28% | +0.20% |
| 4 | Neuland Laboratories Limited ₹25.46 L |
Pharmaceuticals & Biotechnology | 1.02% | 1.21% | +0.19% |
| 5 | IPCA Laboratories Limited ₹35.51 L |
Pharmaceuticals & Biotechnology | 1.51% | 1.69% | +0.18% |
| 6 | Gland Pharma Limited ₹29.43 L |
Pharmaceuticals & Biotechnology | 1.23% | 1.40% | +0.17% |
| 7 | Laurus Labs Limited ₹94.21 L |
Pharmaceuticals & Biotechnology | 4.33% | 4.48% | +0.15% |
| 8 | Aurobindo Pharma Limited ₹60.72 L |
Pharmaceuticals & Biotechnology | 2.74% | 2.89% | +0.15% |
| 9 | Morepen Laboratories Limited ₹4.77 L |
Pharmaceuticals & Biotechnology | 0.12% | 0.23% | +0.11% |
| 10 | Sai Life Sciences Limited ₹25.52 L |
Pharmaceuticals & Biotechnology | 1.11% | 1.21% | +0.10% |
| # | Stock | Sector | Jul 2026 | Aug 2026 | Change |
|---|---|---|---|---|---|
| 1 | Max Healthcare Institute Limited ₹97.13 L |
Healthcare Services | 5.05% | 4.62% | -0.43% |
| 2 | Sun Pharmaceutical Industries Limited ₹2.72 Cr |
Pharmaceuticals & Biotechnology | 13.35% | 12.95% | -0.40% |
| 3 | Lupin Limited ₹68.02 L |
Pharmaceuticals & Biotechnology | 3.64% | 3.24% | -0.40% |
| 4 | Cipla Limited ₹1.03 Cr |
Pharmaceuticals & Biotechnology | 5.18% | 4.91% | -0.27% |
| 5 | Torrent Pharmaceuticals Limited ₹91.69 L |
Pharmaceuticals & Biotechnology | 4.53% | 4.36% | -0.17% |
| 6 | Alkem Laboratories Limited ₹40.42 L |
Pharmaceuticals & Biotechnology | 2.09% | 1.92% | -0.17% |
| 7 | Fortis Healthcare Limited ₹60.95 L |
Healthcare Services | 3.06% | 2.90% | -0.16% |
| 8 | Apollo Hospitals Enterprise Limited ₹1.17 Cr |
Healthcare Services | 5.68% | 5.55% | -0.13% |
| 9 | Aster DM Healthcare Limited ₹25.73 L |
Healthcare Services | 1.35% | 1.22% | -0.13% |
| 10 | Biocon Limited ₹37.22 L |
Pharmaceuticals & Biotechnology | 1.89% | 1.77% | -0.12% |
125 stocks — Aug 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹2.72 Cr |
Pharmaceuticals & Biotechnology |
12.95%
|
|
| 2 |
₹1.52 Cr |
Pharmaceuticals & Biotechnology |
7.22%
|
|
| 3 |
₹1.17 Cr |
Healthcare Services |
5.55%
|
|
| 4 |
₹1.03 Cr |
Pharmaceuticals & Biotechnology |
4.91%
|
|
| 5 |
₹97.13 L |
Healthcare Services |
4.62%
|
|
| 6 |
₹94.21 L |
Pharmaceuticals & Biotechnology |
4.48%
|
|
| 7 |
₹91.69 L |
Pharmaceuticals & Biotechnology |
4.36%
|
|
| 8 |
₹91.48 L |
Pharmaceuticals & Biotechnology |
4.35%
|
|
| 9 |
₹68.02 L |
Pharmaceuticals & Biotechnology |
3.24%
|
|
| 10 |
₹60.95 L |
Healthcare Services |
2.90%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.